Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

C-myc overexpression and p53 loss cooperate to promote genomic instability

Abstract

p53 monitors genomic integrity at the G1 and G2/M cell cycle checkpoints. Cells lacking p53 may show gene amplification as well as the polyploidy or aneuploidy typical of many tumors. The pathways through which this develops, however, are not well defined. We demonstrate here that the combination of p53 inactivation and c-myc overexpression in diploid cells markedly accelerates the spontaneous development of tetraploidy. This is not seen with either N-myc or L-myc. Tetraploidy is accompanied by significantly higher levels of cyclin B and its associated cdc2 kinase activity. Mitotic spindle poisons accelerate the appearance of tetraploidy in cells either lacking functional p53 or overexpressing c-myc whereas the combination is additive. Restoration of p53 function in cells overexpressing c-myc causing rapid apoptosis, indicating that cells yet to become tetraploid have nonetheless suffered irreversible genomic and/or mitotic spindle damage. In the face of normal p53 function, such damage would either be repaired or trigger apoptotis. We propose that loss of p53 and overexpression of c-myc permits the emergence and survival of cells with increasingly severe damage and the eventual development of tetraploidy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Agarwal ML, Agarwal A, Taylor WR and Stark GR. . 1995 Proc. Natl. Acad. Sci. USA 92: 8493–8497.

  • Armelin HA, Armelin CS, Kelly K, Stewart T, Leder P, Cochran BH and Stiles CD. . 1984 Nature 310: 655–660.

  • Ballerini P, Gaidano G, Gong JG, Tassi V, Saglio G, Knowles DM and Dalla-Favera R. . 1993 Blood 81: 166–176.

  • Banks L, Barnett SC and Crook T. . 1990 Oncogene 5: 833–837.

  • Barbosa MS. . 1996 Crit. Rev. Oncogen. 7: 1–18.

  • Barrett J, Birrer MJ, Kato GJ, Dosaka-Akita H and Dang CV. . 1992 Mol. Cell. Biol. 12: 3130–3137.

  • Berns EMJJ, Klijn JGM, Smid M, vanStaveren IL, Look MP, vanPutten WLJ and Foekens JA. . 1996 Genes, Chrom. & Cancer 16: 170–179.

  • Birrer MJ, Segal S, DeGreve JS, Kaye F, Sausville EA and Minna JD. . 1988 Mol. Cell. Biol. 8: 2668–2673.

  • Blandino G, Scardigli R, Rizzo MG, Crescenzi M, Saddu S and Sacchi A. . 1995 Oncogene 10: 731–737.

  • Blount PL, Galipeau PC, Sanchez CA, Neshat K, Levine DS, Yin J, Suzuki H, Abraham JM, Meltzer SJ and Reid BJ. . 1994 Cancer Res. 54: 2292–2295.

  • Carder P, Wyllie AH, Purdie CA, Morris RG, White S, Piris J and Bird CC. . 1993 Oncogene 8: 1397–1401.

  • Coursen JD, Bennett WP, Gollahon L, Shay JW and Harris CC. . 1997 Exp. Cell Res. 235: 245–253.

  • Crook T, Tidy JA and Vousden KH. . 1991 Cell 67: 547–556.

  • Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH and Reid BJ. . 1995 Science 267: 1353–1356.

  • Datta N, Williams JL and Long MW. . 1996 Mol. Biol. Cell 7: 209–223.

  • DiLeonardo A, Linke SP, Clarkin K and Wahl GM. . 1994 Genes Dev. 8: 2540–2551.

  • Eilers M, Schirm S and Bishop JM. . 1991 EMBO J. 10: 133–141.

  • Farrell PJ, Allan GJ, Shanahan F, Vousden KH and Crook T. . 1991 EMBO J. 10: 2879–2885.

  • Farthing AJ and Vousden KH. . 1994 Trends Microbiol. 2: 170–174.

  • Gaidano G, Ballerini P, Gong JG, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM and Dalla-Favera R. . 1991 Proc. Natl. Acad. Sci. USA 88: 5413–5417.

  • Greenberger JS, Sakakeeeny MA, Humphries RK, Eaves CJ and Eckner RJ. . 1983 Proc. Natl. Acad. Sci. USA 80: 2931–2935.

  • Hartwell LH and Kastan MB. . 1994 Science 266: 1821–1827.

  • Harvey M, Sands AT, Weiss RS, Heigi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A and Donehower LA. . 1993 Oncogene 8: 2457–2467.

  • Hiebert SW, Lipp M and Nevins JR. . 1989 Proc. Natl. Acad. Sci. USA 86: 3594–3598.

  • Huibregste JM, Scheffner M and Howley PM. . 1994 Cold Spring Harbor Symp. Quant. Biol. 59: 237–245.

  • Jacks T and Weinberg RA. . 1996 Nature 381: 643–646.

  • Johnson DG, Schwarz JK, Cress WD and Nevins JR. . 1993 Nature 365: 349–352.

  • Karn J, Watson JV, Lowe AD, Green SM and Vedekis W. . 1989 Oncogene 4: 773–787.

  • Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig R. . 1991 Cancer Res. 51: 6304–6311.

  • Kaufmann WK, Schwartz JL, Hurt JC, Byrd LL, Galloway DA, Levedakou E and Paules RS. . 1997 Cell Growth Diff. 8: 1105–1114.

  • Kelly K, Cochran BH, Stiles CD and Leder P. . 1983 Cell 35: 603–610.

  • Ko LJ and Prives C. . 1996 Genes Dev. 10: 1054–1072.

  • Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. . 1992 Proc. Natl. Acad. Sci. USA 89: 7491–7495.

  • Lam EW, Morris JD, Davies R, Crook T, Watson RJ and Vousden KH. . 1994 EMBO J. 13: 871–878.

  • Langlands K and Prochownik EV. . 1997 Anal. Biochem. 249: 250–252.

  • Levine DS, Sanchez CA, Rabinovitch PS and Reid BJ. . 1991 Proc. Natl. Acad. Sci. USA 88: 6427–6431.

  • Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD. . 1992 Cell 70: 923–935.

  • Ma A, Moroy T, Collum R, Weintraub H, Alt FW and Blackwell TK. . 1993 Oncogene 8: 1093–1098.

  • Michalovitz D, Helevy O and Oren M. . 1990 Cell 62: 671–680.

  • Nelson WG and Kastan MB. . 1994 Mol. Cell. Biol. 14: 1815–1823.

  • Nesbit CE, Fan S, Zhang Z and Prochownik EV. . 1998 Blood 92: 1003–1010.

  • Nesbit CE, Grove LE, Yin XY and Prochownik EV. . 1998 Cell Growth & Diff. in press.

  • O'Connor P, Jackman J, Jondle D, Bhatia K, Magrath I and Kohn KW. . 1993 Cancer Res. 53: 4776–4780.

  • Oda D, Bigler L, Mao EJ and Disteche CM. . 1996 Carcinogenesis 17: 2003–2008.

  • Pellegata NS, Antoniono RJ, Redpath JL and Stanbridge EJ. . 1996 Proc. Natl. Acad. Sci. USA 93: 15209–15214.

  • Prochownik EV, Kukowska-Latallo JF and Rodgers C. . 1988 Mol. Cell. Biol. 8: 3683–3695.

  • Prochownik EV and VanAntwerp ME. . 1993 Proc. Natl. Acad. Sci. USA 90: 960–964.

  • Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SEM, Salter DM, Bird CC, Wyllie AH, Hooper ML and Clarke AR. . 1994 Oncogene 9: 603–609.

  • Qin X-Q, Livingston DM, Kaelin WG and Adams P. . 1994 Proc. Natl. Acad. Sci. USA 91: 10918–10922.

  • Ryan JJ, Prochownik EV, Gottlieb CA, Apel IJ and Clarke MF. . 1994 Proc. Natl. Acad. Sci. USA 91: 5878–5882.

  • Sala A, Casella I, Bellon T, Calabretta B, Watson RJ and Peschle C. . 1996 J. Biol. Chem. 271: 9363–9367.

  • Scheffner M, Werness BA, Huibregste JM, Levine AJ and Howley PM. . 1990 Cell 63: 1129–1136.

  • Scheffner M, Huibregste JM, Vierstra RD and Howley PM. . 1993 Cell 75: 495–505.

  • Sorrentino V, Drozdoff V, McKinney MD, Zeitz L and Fleissner E. . 1986 Proc. Natl. Acad. Sci. USA 83: 8167–8171.

  • Stern DF, Roberts AB, Roche NS, Sporn MB and Weinberg RA. . 1986 Mol. Cell. Biol. 6: 870–877.

  • Takata M, Sabe H, Hata A, Inazu T, Homma Y, Nukada T, Yamamura H and Kurosaki T. . 1994 EMBO J. 13: 1341–1349.

  • Tommasino M and Crawford L. . 1995 BioEssays 17: 509–518.

  • Valtieri M, Tweardy DJ, Caracciolo D, Johnson K, Mavilio F, Altmann S, Santoli D and Rovera G. . 1987 J. Immunol. 138: 3829–3834.

  • Vousden KH. . 1995 Semin. Cancer Biol. 6: 109–116.

  • Waldman T, Lengauer C, Kinzler KW and Vogelstein B. . 1996 Nature 381: 713–716.

  • Walker DH, Adaim GR, Dold KM and Babiss LE. . 1995 Cell Growth Diff. 6: 1053–1061.

  • Weinberg RA. . 1995 Cell 81: 323–330.

  • Werness BA, Levine AJ and Howley PM. . 1990 Science 248: 76–79.

  • White AE, Livanes EM and Tlsty TD. . 1994 Genes & Dev. 8: 666–677.

  • Wiman KG, Magnusson KP, Ramqvist T and Klein G. . 1991 Oncogene 6: 1633–1639.

  • Zhang H, Fan S and Prochownik EV. . 1997 J. Biol. Chem. 272: 17416–17424.

Download references

Acknowledgements

We thank Saijun Fan, and Karen Vousden for gifts of wild-type and mutant E6 genes, Mike Clarke for pLTRtsp53-hygro and Susanne Gollin for karyotyping. We also thank Saleem Khan and Jim Pipas for comments on the manuscript. This work was supported by NIH grant HL33741 (to EVP)

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yin, X., Grove, L., Datta, N. et al. C-myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene 18, 1177–1184 (1999). https://doi.org/10.1038/sj.onc.1202410

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202410

Keywords

This article is cited by

Search

Quick links